Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05458167
Other study ID # HEXA study
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 3, 2023
Est. completion date April 3, 2024

Study information

Verified date June 2024
Source Hedia ApS
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomised controlled crossover pilot study to evaluate safety and efficacy of a digital insulin bolus calculator with a physical activity module


Description:

Hedia Diabetes Assistant is a software device intended to monitor blood glucose and to support in the decision making of the optimal bolus insulin dose for management of insulin-dependent diabetes by providing the user with an indicative Bolus insulin dose. This study has been designed to investigate the safety and efficacy of a digital insulin bolus calculator with a physical activity module that provides guidance on insulin reduction to patients with type 1 diabetes mellitus prior to and after exercise, based on exercise duration and intensity compared with the patients' habitual diabetes management.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 3, 2024
Est. primary completion date April 3, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Signed informed consent. - Ability to understand, speak and read Danish fluently. - Diagnosis of type 1 diabetes mellitus for =12 months. - Age between =18 and <60 years. - Minimum one measurement of HbA1c between 6.0 to 8.6 % (42 to 70 mmol/mol) within the last four months. If several measurements, then it is the latest one that counts. - Body mass index (BMI) between =18.5 and <30 kg/m2. - Ability to use an Apple® (iOS version 13 and up) or Android® (Android version 8.0 and up) smartphone. - Treated with the same pen-based insulin regimen with basal insulin (insulin glargine, degludec, or detemir) and meal time insulin (insulin aspart, lispro, glulisine) for at least the three preceding months. - Patients who can perform 45 min. of exercise at moderate intensity on an ergometer bike (investigator assessment). - If female participants of childbearing potential; willing to have a pregnancy test performed and to use a highly effective method of contraception. Exclusion Criteria: - Already using Hedia Diabetes Assistant. - Use of human insulin or premixed insulin. - Blood pressure > 180/105 mmHg. - Treatment with sodium-glucose transporter 2-inhibitors, glucagon-like peptide 1 receptor agonists, or glucocorticoids. - Job situation entailing night shifts. - Fever. - A mental state impeding compliance with the protocol. - Expected non-compliance with the protocol at the discretion of the principal investigator. - Pregnancy. - Breast-feeding. - Dialysis therapy or eGFR < 60 ml/min. - Patients diagnosed with claudicatio intermittens, heart failure, ischaemic heart disease or stroke. - Patients prescribed with beta blockers. - Abuse of alcohol or drugs in the past two years. - On-going participation, or participation within the last 3 months, in an organised clinical study in which participants received study medication (investigator assessment). - Surgery scheduled for the study duration period. - An episode of diabetic ketoacidosis or severe hypoglycaemia requiring third-party assistance within the preceding 6 months. - Known gastroparesis.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Hedia Diabetes Assistant bolus calculator with a physical activity module
Hedia Diabetes Assistant bolus calculator with a physical activity module is a software device that calculates an insulin bolus based on blood glucose, carbohydrates and physical activity.

Locations

Country Name City State
Denmark North Zealand Hospital - Hillerød Hillerød

Sponsors (1)

Lead Sponsor Collaborator
Hedia ApS

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Glycemic variability of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of glycaemic variability (coefficient of variation and standard deviation). 24-hour period starting one hour before exercise
Other Daily insulin requirement of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the daily intake of insulin in adults with type 1 diabetes mellitus utilising the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to their habitual diabetes management during a 24-hour period starting one hour before exercise. 24-hour period starting one hour before exercise
Other Daily correctional actions of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the number of daily correctional actions (intake of food or injection of insulin) in adults with type 1 diabetes mellitus utilising the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to their habitual diabetes management during a 24-hour period starting one hour before exercise. 24-hour period starting one hour before exercise
Other Usability of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the usability of the physical activity module as part of the Hedia Diabetes Assistant application by System Usability Scale (SUS) in adult patients with type 1 diabetes mellitus. 1 day
Primary Time-in-range of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-in-range (blood glucose 3.9-10.0 mmol/l). 24-hour period starting one hour before exercise
Secondary Hypoglycemic events of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of no. of hypoglycemic events (blood glucose < 3.9 mmol/l). 24-hour period starting one hour before exercise
Secondary Time-above-range of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-above-range (>10.0 mmol/l). 24-hour period starting one hour before exercise
Secondary Time-below-range of Hedia Diabetes Assistant bolus calculator with physical activity module To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-below-range (blood glucose < 3.9 mmol/l). 24-hour period starting one hour before exercise
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4